Oxford Global Conferences are proud to present our Cell & Gene Therapy Congress, taking place on the 9th & 10th November 2015 in London, United Kingdom. This event will be co-located with our prestigious 4th Annual Cell Culture & Bioprocessing Congress, as well as our 2nd Annual Stem Cell Congress.
Cell therapy is an area with enormous potential for the pharmaceutical industry, and major companies across the globe are beginning to make important advances in the field, and experts are expecting the first therapies based on precise genome-editing to be on the market well within the next decade. This congress offers invaluable insights into key technological and scientific advances, addressing the most pressing challenges in the cell and gene therapy industry from the discovery of novel therapies through to the very latest clinical trial case studies and a look at the future of bringing cell therapies to market.
The first day of the conference will look at the development of cell therapies, as well as clinical trial case studies and strategies for commercialisation of successful treatments. The latest developments in the use of gene-editing tools will be one of the highlights of the discussions, as well as looking at case studies of positive clinical data.
Our second day will focus on the challenges associated with the bioprocessing and manufacture of cell therapies. Hot topics will include approaches to producing innovative gene delivery mechanisms including transposon technology, as well as cutting edge technologies and solutions for manufacture of raw materials.
Over two days, the congress will attract senior-level decision makers working at the forefront of the cell therapy industry from the US and Europe. The conference programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, as well as ample networking opportunities, creating an interactive platform for high-level scientific and business discussion.
Executive VP, Adaptimmune
Head of Process Development, Cell Therapy Catapult
Head of Commercial, Cell Therapy Catapult
Professor, Sir William Dunn School of Pathology, University of Oxford
Professor Translational Medicine, University of Reading
Director, Cellular Therapy Quality Management, Moffitt Cancer Centre
Founder, Chairman & CSO, Celgene
Executive Vice President, Athersys
Professor, MDC Berlin
Director Cell Therapy Facility, Moffitt Cancer Centre
Professor of Molecular Dermatology, King’s College London
Head of Early Discovery, Cellectis
Scientific Director, Stem Cells Research, Janssen
Vice President Corporate Development, Hemostemix
Senior Scientist, Pfizer
Vice President Pre-Clinical Research, Bluebird Bio
In keeping with Oxford Global’s highly successful life sciences series, an expert panel of over 80 speakers will present a full conference programme covering the topics outlined below.
Day 1 – Cell & Gene Therapy: Development, Clinical Trials & Commercialisation
- Development of gene and advanced therapies
- Application of novel genome editing tools inc. CRISPR & TALEN
- Innovative technologies for development and administration inc. gene therapy delivery
- Cell & gene therapy commercialisation strategies and business models
- The latest clinical trial studies
- The latest innovations in CAR-T cell-based therapies
Day 2 – Cell Therapy Bioprocessing
- Effective scale-up of manufacturing for viral vectors & autologous cellular therapies
- Upstream & downstream processing of vectors & cells
- Effective assay development for cell therapies
- Manufacture of genetically modified T-cells
- Successful technology transfer
- Production of plasmids and vectors inc. transposon-based gene delivery
Submit a poster
For attendees interested in submitting a poster, there are opportunities now available. Your poster presentation will be located in the exhibition room for two days alongside other posters from senior scientists working in industry and academia.
How to submit your abstract
We will require:
- Poster title, Abstract (200 words or less)
- Principal author, Organisation
- Mailing address, Email, Telephone, Fax
- Additional authors
In order to secure your board space a fee of £250 plus VAT will be required. The poster should be presented as A0 (841mm x 1189mm) portrait size.To take advantage of this opportunity you need to be registered as a paid delegate over the 2 days. We have limited spaces available, so please register soon!